Target Name: PTPRE
NCBI ID: G5791
Review Report on PTPRE Target / Biomarker Content of Review Report on PTPRE Target / Biomarker
PTPRE
Other Name(s): PTPRE variant 1 | Protein tyrosine phosphatase receptor type E, transcript variant 2 | OTTHUMP00000020735 | Protein tyrosine phosphatase, receptor type, epsilon polypeptide | PTPE | DKFZp313F1310 | R-PTP-epsilon | FLJ58245 | Protein tyrosine phosphatase receptor type E, transcript variant 1 | Receptor-type protein tyrosine phosphatase E | PTPRE variant 2 | Receptor-type tyrosine-protein phosphatase epsilon (isoform 1) | R-PTP-EPSILON | Protein-tyrosine phosphatase epsilon | Receptor-type tyrosine-protein phosphatase epsilon (isoform 2) | PTPRE_HUMAN | protein tyrosine phosphatase, receptor type, epsilon polypeptide | FLJ57799 | protein tyrosine phosphatase receptor type E | OTTHUMP00000020736 | HPTPE | Receptor-type tyrosine-protein phosphatase epsilon

Identifying and Analyzing PTPRE: A Potential Drug Target

Post-Translational Processing (PTP) RNA variants have been identified as potential drug targets in various diseases. One of the most well-known variants is PTPRE (PTPRE variant 1). PTPRE is a processed RNA molecule that is generated from a specific template gene . It is a key regulator of gene expression and has been implicated in the development and progression of various diseases, including cancer. In this article, we will discuss the biology of PTPRE, its potential as a drug target, and the current research efforts to target this molecule.

Biology of PTPRE

PTPRE is a 21-kDa RNA molecule that is generated from a specific template gene. The template gene is responsible for producing PTPRE, which is then processed to create a unique RNA molecule. PTPRE has been shown to have various functions in various cell types, including regulating gene expression, activating transcription factors, and modulating the immune response.

One of the most significant functions of PTPRE is its role in regulating gene expression. PTPRE has been shown to interact with various transcription factors, including activating the transcription factor CREB and suppressing the transcription factor FOXO3. PTPRE has also been shown to play a role in regulating microRNA (miRNA) expression, which are small non-coding RNAs that play a critical role in post-transcriptional gene regulation.

In addition to its role in gene expression, PTPRE has also been shown to play a key role in the regulation of cellular processes that are critical for human health, including the development and progression of cancer. For example, PTPRE has been shown to promote the growth and survival of cancer cells, and it has also been shown to inhibit the anti-cancer effects of various therapeutic drugs.

Potential as a Drug Target

The potential of PTPRE as a drug target is based on its various functions in cellular processes that are critical for human health. One of the most promising aspects of PTPRE as a drug target is its ability to modulate the expression of genes that are involved in cancer development.

For example, PTPRE has been shown to promote the growth and survival of various cancer cell types, including breast, ovarian, and colorectal cancer. This suggests that PTPRE may be an attractive target for cancer therapies that are designed to inhibit its activity. In addition , PTPRE has also been shown to contribute to the development of resistance to anti-cancer drugs, which may make it an even more attractive target for cancer therapies.

Another promising aspect of PTPRE as a drug target is its ability to modulate the expression of genes involved in cellular processes that are important for human health. For example, PTPRE has been shown to regulate the production of pro-inflammatory cytokines, which can contribute to the development of various inflammatory diseases, including cardiovascular disease and autoimmune disorders.

In addition to its potential as a cancer drug target, PTPRE has also been shown to have potential as a biomarker. The expression of PTPRE has been shown to be associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that PTPRE may be a valuable biomarker for the diagnosis and treatment of these diseases.

Current Research Efforts

Current research efforts are focused on understanding the biology of PTPRE and its potential as a drug target and biomarker. One of the most significant areas of research is the study of PTPRE's role in regulating gene expression. This includes studies of its interaction with transcription factors, as well as its regulation of miRNA expression.

Another area of 鈥嬧?媟esearch is the study of PTPRE's potential as a drug target. This includes studies of its effects on cancer cell growth and survival, as well as its contribution to the development of resistance to anti-cancer drugs.

In addition to these areas of research, there is also

Protein Name: Protein Tyrosine Phosphatase Receptor Type E

Functions: Isoform 1 plays a critical role in signaling transduction pathways and phosphoprotein network topology in red blood cells. May play a role in osteoclast formation and function (By similarity)

The "PTPRE Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PTPRE comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PTPRF | PTPRG | PTPRH | PTPRJ | PTPRK | PTPRM | PTPRN | PTPRN2 | PTPRN2-AS1 | PTPRO | PTPRQ | PTPRR | PTPRS | PTPRT | PTPRU | PTPRVP | PTPRZ1 | PTRH1 | PTRH2 | PTRHD1 | PTS | PTTG1 | PTTG1IP | PTTG2 | PTTG3P | PTX3 | PTX4 | PUDP | PUDPP2 | PUF60 | PUM1 | PUM2 | PUM3 | PURA | PURB | PURG | PURPL | PUS1 | PUS10 | PUS3 | PUS7 | PUS7L | PUSL1 | Putative POM121-like protein 1 | Putative uncharacterized protein C12orf63 | PVALB | PVALEF | PVR | PVRIG | PVT1 | PWAR1 | PWAR4 | PWAR5 | PWAR6 | PWARSN | PWP1 | PWP2 | PWRN1 | PWRN2 | PWRN3 | PWWP2A | PWWP2B | PWWP3A | PWWP3B | PXDC1 | PXDN | PXDNL | PXK | PXMP2 | PXMP4 | PXN | PXN-AS1 | PXT1 | PXYLP1 | PYCARD | PYCR1 | PYCR2 | PYCR3 | PYDC1 | PYDC2 | PYDC2-AS1 | PYGB | PYGL | PYGM | PYGO1 | PYGO2 | PYHIN1 | PYM1 | PYROXD1 | PYROXD2 | Pyruvate Dehydrogenase Complex | Pyruvate dehydrogenase kinase | Pyruvate Kinase | PYY | PYY2 | PZP | QARS1 | QDPR | QKI | QPCT